Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;101:268-276
Published online before print June 21, 2007, doi: 10.1161/CIRCRESAHA.107.150474
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
101/3/268    most recent
CIRCRESAHA.107.150474v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henke, N.
Right arrow Articles by Muller, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henke, N.
Right arrow Articles by Muller, D. N.
Related Collections
Right arrowRelated Article
(Circulation Research. 2007;101:268.)
© 2007 American Heart Association, Inc.


Molecular Medicine

Vascular Endothelial Cell–Specific NF-{kappa}B Suppression Attenuates Hypertension-Induced Renal Damage

Norbert Henke, Ruth Schmidt-Ullrich, Ralf Dechend, Joon-Keun Park, Fatimunnisa Qadri, Maren Wellner, Michael Obst, Volkmar Gross, Rainer Dietz, Friedrich C. Luft, Claus Scheidereit, Dominik N. Muller

From the Medical Faculty of the Charité (N.H., R.D., M.W., R.D., F.C.L., D.N.M.), Franz Volhard Clinic, HELIOS Klinikum-Berlin; the Max-Delbrück-Center for Molecular Medicine (R.S.-U., F.Q., M.O., V.G., F.C.L., C.S., D.N.M.), Berlin-Buch; and the Medical School of Hannover (J.-K.P.), Hannover, Germany.

Correspondence to Ruth Schmidt-Ullrich, PhD, Max-Delbrück-Center, Robert-Rossle Street 50, 13125 Berlin-Buch, Germany. E-mail rschmidt{at}mdc-berlin.de

Nuclear factor kappa B (NF-{kappa}B) participates in hypertension-induced vascular and target-organ damage. We tested whether or not endothelial cell–specific NF-{kappa}B suppression would be ameliorative. We generated Cre/lox transgenic mice with endothelial cell–restricted NF-{kappa}B super-repressor I{kappa}B{alpha}{Delta}N (Tie-1-{Delta}N mice) overexpression. We confirmed cell-specific I{kappa}B{alpha}{Delta}N expression and reduced NF-{kappa}B activity after TNF-{alpha} stimulation in primary endothelial cell culture. To induce hypertension with target-organ damage, we fed mice a high-salt diet and N(omega)-nitro-L-arginine-methyl-ester (L-NAME) and infused angiotensin (Ang) II. This treatment caused a 40-mm Hg blood pressure increase in both Tie-1-{Delta}N and control mice. In contrast to control mice, Tie-1-{Delta}N mice developed a milder renal injury, reduced inflammation, and less albuminuria. RT-PCR showed significantly reduced expression of the NF-{kappa}B targets VCAM-1 and ICAM-1, compared with control mice. Thus, the data demonstrate a causal link between endothelial NF-{kappa}B activation and hypertension-induced renal damage. We conclude that in vivo NF-{kappa}B suppression in endothelial cells stops a signaling cascade leading to reduced hypertension-induced renal damage despite high blood pressure.


Key Words: hypertension • endothelium • NF-{kappa}B • target-organ damage


Related Article:

Endothelial NF-{kappa}B As a Mediator of Kidney Damage: The Missing Link Between Systemic Vascular and Renal Disease?
Tomasz J. Guzik and David G. Harrison
Circ. Res. 2007 101: 227-229. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
FASEB J.Home page
C. Colussi, A. Gurtner, J. Rosati, B. Illi, G. Ragone, G. Piaggio, M. Moggio, C. Lamperti, G. D'Angelo, E. Clementi, et al.
Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy
FASEB J, July 1, 2009; 23(7): 2131 - 2141.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Hagiwara, G. Bledsoe, Z.-R. Yang, R. S. Smith Jr., L. Chao, and J. Chao
Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress
Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1735 - F1743.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
X. Ye, J. Ding, X. Zhou, G. Chen, and S. F. Liu
Divergent roles of endothelial NF-{kappa}B in multiple organ injury and bacterial clearance in mouse models of sepsis
J. Exp. Med., June 9, 2008; 205(6): 1303 - 1315.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Shen, M. Hagiwara, Y.-Y. Yao, L. Chao, and J. Chao
Salutary Effect of Kallistatin in Salt-Induced Renal Injury, Inflammation, and Fibrosis via Antioxidative Stress
Hypertension, May 1, 2008; 51(5): 1358 - 1365.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. F. E. Mann
What's new in hypertension 2007?
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 466 - 470.
[Full Text] [PDF]


Home page
HypertensionHome page
A. Yogi, C. Mercure, J. Touyz, G. E. Callera, A. C.I. Montezano, A. B. Aranha, R. C. Tostes, T. Reudelhuber, and R. M. Touyz
Renal Redox-Sensitive Signaling, but Not Blood Pressure, Is Attenuated by Nox1 Knockout in Angiotensin II-Dependent Chronic Hypertension
Hypertension, February 1, 2008; 51(2): 500 - 506.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
D. N Muller
Mechanisms of hypertension-induced target organ damage
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2007; 8(3): 148 - 150.
[PDF]


Home page
Circ. Res.Home page
T. J. Guzik and D. G. Harrison
Endothelial NF-{kappa}B As a Mediator of Kidney Damage: The Missing Link Between Systemic Vascular and Renal Disease?
Circ. Res., August 3, 2007; 101(3): 227 - 229.
[Full Text] [PDF]